• AMD (Age-Related Macular Degeneration) is the leading cause of blindness in patients over 60 in the US.1
  • Early detection and even prediction of those who will develop AMD are vital goals that are beginning to be met with myriad new technologies, including genetic testing.
  • This issue will introduce several new technologies aimed towards the early detection and treatment of AMD. These technologies include: MDD-2 Macular Adaptometer, Reichert Foresee PHP® (Preferential Hyperacuity Perimeter), Foresee Home AMD Monitor, MAIA™ (Macular Integrity Assessment), Annidis: The RHA (Retinal Health Assessment), Arctic Dx: Macula Risk®, Macuscope, ZeaVision’s QuantifEYE®, Optos® Panoramic FAF (F-undus Autofluorescence), and SD-OCT.